These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 26121043

  • 1. Resibufogenin Induces G1-Phase Arrest through the Proteasomal Degradation of Cyclin D1 in Human Malignant Tumor Cells.
    Ichikawa M, Sowa Y, Iizumi Y, Aono Y, Sakai T.
    PLoS One; 2015; 10(6):e0129851. PubMed ID: 26121043
    [Abstract] [Full Text] [Related]

  • 2. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
    Ong CS, Zhou J, Ong CN, Shen HM.
    Cancer Lett; 2010 Dec 08; 298(2):167-75. PubMed ID: 20655656
    [Abstract] [Full Text] [Related]

  • 3. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.
    Masamha CP, Benbrook DM.
    Cancer Res; 2009 Aug 15; 69(16):6565-72. PubMed ID: 19638577
    [Abstract] [Full Text] [Related]

  • 4. Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest.
    Bai J, Nakamura H, Ueda S, Kwon YW, Tanaka T, Ban S, Yodoi J.
    J Biol Chem; 2004 Sep 10; 279(37):38710-4. PubMed ID: 15247282
    [Abstract] [Full Text] [Related]

  • 5. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
    Dong J, Peng J, Zhang H, Mondesire WH, Jian W, Mills GB, Hung MC, Meric-Bernstam F.
    Cancer Res; 2005 Mar 01; 65(5):1961-72. PubMed ID: 15753396
    [Abstract] [Full Text] [Related]

  • 6. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway.
    Xu G, Li Y, Yoshimoto K, Wu Q, Chen G, Iwata T, Mizusawa N, Wan C, Nie X.
    Toxicol Lett; 2014 Jan 30; 224(3):362-70. PubMed ID: 24231000
    [Abstract] [Full Text] [Related]

  • 7. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells.
    Takahashi-Yanaga F, Taba Y, Miwa Y, Kubohara Y, Watanabe Y, Hirata M, Morimoto S, Sasaguri T.
    J Biol Chem; 2003 Mar 14; 278(11):9663-70. PubMed ID: 12522140
    [Abstract] [Full Text] [Related]

  • 8. A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activity.
    Ramljak D, Calvert RJ, Wiesenfeld PW, Diwan BA, Catipovic B, Marasas WF, Victor TC, Anderson LM, Gelderblom WC.
    Carcinogenesis; 2000 Aug 14; 21(8):1537-46. PubMed ID: 10910956
    [Abstract] [Full Text] [Related]

  • 9. Arsenic trioxide suppressed mantle cell lymphoma by downregulation of cyclin D1.
    Lo RK, Kwong YL.
    Ann Hematol; 2014 Feb 14; 93(2):255-65. PubMed ID: 23949314
    [Abstract] [Full Text] [Related]

  • 10. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
    Mori J, Takahashi-Yanaga F, Miwa Y, Watanabe Y, Hirata M, Morimoto S, Shirasuna K, Sasaguri T.
    Exp Cell Res; 2005 Nov 01; 310(2):426-33. PubMed ID: 16153639
    [Abstract] [Full Text] [Related]

  • 11. GSK3β-dependent cyclin D1 and cyclin E1 degradation is indispensable for NVP-BEZ235 induced G0/G1 arrest in neuroblastoma cells.
    Liu SL, Liu Z, Zhang LD, Zhu HQ, Guo JH, Zhao M, Wu YL, Liu F, Gao FH.
    Cell Cycle; 2017 Nov 01; 16(24):2386-2395. PubMed ID: 28980866
    [Abstract] [Full Text] [Related]

  • 12. Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation.
    Cheng YH, Li LA, Lin P, Cheng LC, Hung CH, Chang NW, Lin C.
    Toxicol Appl Pharmacol; 2012 Sep 15; 263(3):360-7. PubMed ID: 22820424
    [Abstract] [Full Text] [Related]

  • 13. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.
    Alao JP, Stavropoulou AV, Lam EW, Coombes RC, Vigushin DM.
    Mol Cancer; 2006 Feb 20; 5():8. PubMed ID: 16504004
    [Abstract] [Full Text] [Related]

  • 14. Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells.
    Hsieh TC, Yang CJ, Lin CY, Lee YS, Wu JM.
    Carcinogenesis; 2012 Mar 20; 33(3):670-7. PubMed ID: 22266466
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells.
    Liu L, Zhang H, Shi L, Zhang W, Yuan J, Chen X, Liu J, Zhang Y, Wang Z.
    Oncol Rep; 2014 Oct 20; 32(4):1395-400. PubMed ID: 25109327
    [Abstract] [Full Text] [Related]

  • 16. Effects of the GSK-3β inhibitor (2Z,3E)-6-bromoindirubin-3'-oxime upon ovarian cancer cells.
    Yu AS, Zhao L.
    Tumour Biol; 2016 Apr 20; 37(4):4857-64. PubMed ID: 26526575
    [Abstract] [Full Text] [Related]

  • 17. PSAT1 regulates cyclin D1 degradation and sustains proliferation of non-small cell lung cancer cells.
    Yang Y, Wu J, Cai J, He Z, Yuan J, Zhu X, Li Y, Li M, Guan H.
    Int J Cancer; 2015 Feb 15; 136(4):E39-50. PubMed ID: 25142862
    [Abstract] [Full Text] [Related]

  • 18. Knockdown of human deubiquitinase PSMD14 induces cell cycle arrest and senescence.
    Byrne A, McLaren RP, Mason P, Chai L, Dufault MR, Huang Y, Liang B, Gans JD, Zhang M, Carter K, Gladysheva TB, Teicher BA, Biemann HP, Booker M, Goldberg MA, Klinger KW, Lillie J, Madden SL, Jiang Y.
    Exp Cell Res; 2010 Jan 15; 316(2):258-71. PubMed ID: 19732767
    [Abstract] [Full Text] [Related]

  • 19. Progesterone inhibits the estrogen-induced phosphoinositide 3-kinase-->AKT-->GSK-3beta-->cyclin D1-->pRB pathway to block uterine epithelial cell proliferation.
    Chen B, Pan H, Zhu L, Deng Y, Pollard JW.
    Mol Endocrinol; 2005 Aug 15; 19(8):1978-90. PubMed ID: 15845746
    [Abstract] [Full Text] [Related]

  • 20. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
    Suzui M, Masuda M, Lim JT, Albanese C, Pestell RG, Weinstein IB.
    Cancer Res; 2002 Jul 15; 62(14):3997-4006. PubMed ID: 12124333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.